OPKO Health Basic Shares Outstanding 2010-2024 | OPK

OPKO Health basic shares outstanding from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
OPKO Health Annual Basic Shares Outstanding
(Millions of US $)
2023 $752
2022 $719
2021 $648
2020 $641
2019 $595
2018 $563
2017 $559
2016 $551
2015 $488
2014 $422
2013 $355
2012 $296
2011 $281
2010 $255
2009 $233
OPKO Health Quarterly Basic Shares Outstanding
(Millions of US $)
2024-09-30 $695
2024-06-30 $697
2024-03-31 $707
2023-12-31 $752
2023-09-30 $752
2023-06-30 $752
2023-03-31 $752
2022-12-31 $719
2022-09-30 $750
2022-06-30 $713
2022-03-31 $660
2021-12-31 $648
2021-09-30 $652
2021-06-30 $647
2021-03-31 $641
2020-12-31 $641
2020-09-30 $641
2020-06-30 $641
2020-03-31 $641
2019-12-31 $595
2019-09-30 $586
2019-06-30 $586
2019-03-31 $586
2018-12-31 $563
2018-09-30 $560
2018-06-30 $560
2018-03-31 $559
2017-12-31 $559
2017-09-30 $559
2017-06-30 $559
2017-03-31 $558
2016-12-31 $551
2016-09-30 $552
2016-06-30 $548
2016-03-31 $546
2015-12-31 $488
2015-09-30 $501
2015-06-30 $462
2015-03-31 $446
2014-12-31 $422
2014-09-30 $428
2014-06-30 $413
2014-03-31 $413
2013-12-31 $355
2013-09-30 $361
2013-06-30 $337
2013-03-31 $313
2012-12-31 $296
2012-09-30 $298
2012-06-30 $298
2012-03-31 $298
2011-12-31 $281
2011-09-30 $286
2011-06-30 $285
2011-03-31 $261
2010-12-31 $255
2010-09-30 $255
2010-06-30 $255
2010-03-31 $254
2009-12-31 $233
2009-09-30 $253
2009-06-30 $226
2009-03-31 $200
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.990B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $199.883B 24.39
Intuitive Surgical (ISRG) United States $186.649B 97.58
Edwards Lifesciences (EW) United States $42.814B 27.19
Alcon (ALC) Switzerland $41.161B 27.54
IQVIA Holdings (IQV) United States $35.414B 19.51
IDEXX Laboratories (IDXX) United States $33.479B 39.43
DexCom (DXCM) United States $30.662B 46.18
Waters (WAT) United States $21.866B 32.33
STERIS (STE) Ireland $19.984B 23.01
SONOVA HOLDING (SONVY) Switzerland $19.343B 0.00
Hologic (HOLX) United States $16.281B 17.58
Fresenius Medical Care AG KGaA (FMS) Germany $12.998B 13.34
Sysmex ADR (SSMXY) Japan $11.450B 35.90
Globus Medical (GMED) United States $11.143B 28.22
Penumbra (PEN) United States $9.211B 90.22
Masimo (MASI) United States $9.025B 43.67
Teleflex (TFX) United States $8.316B 13.26
Glaukos (GKOS) United States $8.253B 0.00
Integer Holdings (ITGR) United States $4.433B 25.13
PROCEPT BioRobotics (PRCT) United States $4.340B 0.00
Veracyte (VCYT) United States $3.134B 94.05
Inari Medical (NARI) United States $3.033B 0.00
LivaNova (LIVN) United Kingdom $2.533B 14.62
Tandem Diabetes Care (TNDM) United States $2.354B 0.00
Nihon Kohden (NHNKY) Japan $2.318B 17.61
TransMedics (TMDX) United States $2.232B 70.75
Elekta AB (EKTAY) Sweden $2.095B 18.83
Integra LifeSciences Holdings (IART) United States $1.776B 9.28
RxSight (RXST) United States $1.393B 0.00
Alphatec Holdings (ATEC) United States $1.285B 0.00
Artivion (AORT) United States $1.177B 78.00
Pulse Biosciences (PLSE) United States $1.094B 0.00
Paragon 28 (FNA) United States $0.897B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.728B 12.37
AxoGen (AXGN) United States $0.722B 0.00
Mesa Laboratories (MLAB) United States $0.717B 16.90
IRadimed (IRMD) United States $0.696B 37.63
ORTHOFIX MEDICAL INC (OFIX) United States $0.660B 0.00
SiBone (SIBN) United States $0.584B 0.00
OrthoPediatrics (KIDS) United States $0.554B 0.00
Semler Scientific (SMLR) United States $0.506B 26.63
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.490B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.411B 22.23
Delcath Systems (DCTH) United States $0.403B 0.00
AngioDynamics (ANGO) United States $0.365B 0.00
NeuroPace (NPCE) United States $0.346B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.219B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Anteris Technologies Global (AVR) Australia $0.199B 0.00
Accuray (ARAY) United States $0.196B 0.00
Sight Sciences (SGHT) United States $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.178B 0.00
Nevro (NVRO) United States $0.139B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
LENSAR (LNSR) United States $0.101B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.082B 0.00
908 Devices (MASS) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
WORK Medical Technology Group (WOK) China $0.070B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Covalon Technologies (CVALF) Canada $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.051B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Neuronetics (STIM) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
NexGel (NXGL) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.019B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00